Demant focuses on long-term hearing strategy, shares on Copenhagen
27.06.2026 - 10:35:40 | ad-hoc-news.de
By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-27, 10:35.
Demant (DK0010268440) is a long-established Danish hearing healthcare group. The stock trades on Nasdaq Copenhagen, where it is part of the OMX Copenhagen benchmark universe alongside peers such as GN Store Nord.
How Demant makes its money
Demant’s business model is focused on hearing healthcare, spanning hearing aids, diagnostic equipment and communications solutions. The group reports in distinct segments including Hearing Care, Hearing Aids and Communications, each contributing differently to revenue and profitability.
The Hearing Care segment operates retail chains and independent clinics that sell and fit hearing aids for end users. This segment typically delivers recurring revenue through follow-up services and device upgrades over time.
Strategic priorities in hearing care
In strategy presentations Demant highlights long-term priorities such as expanding its retail footprint, investing in audiology expertise and integrating its product offering across channels. Management positions the company as a full-service provider in hearing healthcare rather than a pure device manufacturer.
Against competitors like GN Store Nord and Sonova, Demant seeks to defend and grow market share through technology, service quality and presence in key geographies. The company reports that aging populations in Europe, North America and Asia remain a structural driver for demand.
Background and price data on Demant
For more detail on the Demant shares, including historical performance and company disclosures, see the dedicated topic page and the investor relations site.
The hearing aid products
Demant’s core products include modern digital hearing aids sold under brands such as Oticon and Bernafon. These devices use advanced signal processing to improve speech understanding and comfort for users with various degrees of hearing loss.
The company also offers fitting software and wireless accessories, which help audiologists tailor solutions and connect hearing aids to phones and televisions. This ecosystem approach supports cross-selling and user retention over time.
Where the stock trades today
Demant shares (DK0010268440) trade on Nasdaq Copenhagen in Danish kroner. As of the latest available exchange data the stock is quoted intraday in Copenhagen, with price and market cap updated continuously by the exchange and data providers.
Demant at a glance
- Company: Demant A/S
- ISIN: DK0010268440
- WKN: (not live-verifiable)
- Ticker: DEMANT
- Trading venue: Nasdaq Copenhagen
- Price (as of latest intraday data): [value] DKK
- Market cap: [value] DKK (as of latest data)
- Sector / industry: Health Care – Medical Devices / Hearing Healthcare
- Index membership: OMX Copenhagen benchmark universe
- Next earnings date: not officially scheduled
Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation or an offer to buy or sell securities. All data are based on publicly available sources believed to be reliable but may be subject to change.
